SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field. For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.
Topics: Organ-on-chips, microfluidics, cell culture, 3D cell culture, 3D bioprinting, bioprinting, organoid, extracellular matrix, ECM, tissue engineering, physiochemical factors, cell-based assay, cytotoxicity, cell metabolic pathways, cancer research, molecular diagnostics, cell and gene therapy, microphysiological, co-culture systems complex in-vitro models, high throughput screening, 3D imaging, drug screening, extracellular matrix scaffolds, 3D drug development, regenerative therapies